Presentation is loading. Please wait.

Presentation is loading. Please wait.

OVERVIEW BIOTECHNOLOGY IN INDONESIA T.Basuki, L.B.S. Kardono & M. Hanafi Research Center for Chemistry Indonesian Institute of Sciences (LIPI)

Similar presentations


Presentation on theme: "OVERVIEW BIOTECHNOLOGY IN INDONESIA T.Basuki, L.B.S. Kardono & M. Hanafi Research Center for Chemistry Indonesian Institute of Sciences (LIPI)"— Presentation transcript:

1 OVERVIEW BIOTECHNOLOGY IN INDONESIA T.Basuki, L.B.S. Kardono & M. Hanafi Research Center for Chemistry Indonesian Institute of Sciences (LIPI)

2

3 Biotechnology, in wider sense, in Indonesia can be said having meaning both of old biotechnology (such as tempe-fermented soybean, tape-fermented cassava/glutinous rice) and new biotechnology (such as protein structure, third generation biotechnology) 1. Biotechnology consists of Traditional and Modern Biotech: Medical, Agro, Environmental, Chemical, and Food Biotechnology 2. Third Generation Biotech= Functional Genomics and Proteomics 3. Targeted Medicine, Tissue Engineering and Stem cells, should be the Focus for Asia 4. BINASIA should become the Information Hub for Biotech Asia 5. Governments must stimulate Innovation in R&D through various Incentives

4

5

6 The Central Dogma of Molecular Biology

7 The Scientific Development of Biotechnology and Its Industrial Applications

8

9

10

11

12 Targeted medicine, Tissue engineering and Stem cells Because people have a different genetic make up, the effect of drugs will also differ. This new branch of medicine is now called pharmacogenetics, which study the effect of drugs on genetically different populations. It is now known that treatment of hypertension, cancers, and other diseases will result in a negative response in certain groups of patients, resulting in waste of money as well as exposing unnecessary adverse reactions to patients.

13 TARGETED THERAPY Targeted therapy addresses the needs of specific patient populations. Patients want to know whether they are likely to benefit from a drug, while minimizing their risk of negative side effects. Targeted medicine may improve drug efficacy by better understanding the genetic associations to disease. Identifying patients most likely respond to a specific drug will improve patient compliance with a therapy. This is especially true in patients with oncology therapy, where the side effect are severe. Herceptin, a drug for breast cancer patients is the prototype drug.

14 TISSUE ENGINEERING Tissue engineering, is also a new field and hold many promises and potentials for future therapy. From the internet, the topic of tissue engineering generates a response of 593,000 hits. So, enough literature to search and read.

15 STEM CELLS Stem cell or Regenerative Medicine is very much related with tissue engineering. It is basically a new science which is developed from embryology and cloning research. When an oocyte is fertilized by sperm to become a zygote, at the blastocyst stage, an inner mass is formed, which is pluripotent, meaning that these cells can differentiate into all 210 tissue in the body. Presently, much research is done to direct the development of these embryonic stem cells, to cardiomyocytes, dopaminergic nerve cells, beta-cells of Langerhans, and neurons. In mice, good results have been achieved to replace infarcted tissue by new cardiomyocytes, pancreatic cells, neurons and other tissues.

16 The Future of Regenerative Medicine/Stem Cells

17

18 Nucleus of patient transferred to enucleated human oocyte. Inner cell mass from blastocyst cultured and stimulated to form specific cell types required for THERAPY----Diabetes, Parkinson, Cancer, Stroke etc,

19 The Chemo- attractive homing hypothesis of circulating STEM CELLS, attracted to injury, in the infarcted area

20 Biotechnology: Present and Future

21 Development of Biotechnology in Indonesia is started in the mid 1980s Under the coordination of Ministry of Education Ministry of Research and Technology Ministry of Agriculture Ministry of Health

22 INDONESIA BIOTECHNOLOGY CONSORTIUM (Konsorsium Bioteknologi Indonesia) Established on October 14, Institutions: 11 (RC); 10 (University), 3 (BPPT), 5 Industries, 2 Hospitals Founding members: 3 IUC Biotechnology (ITB, IPB, UGM) Members : RC from Universities (Public and Private) RC from Department and non-Department Institutions from private sectors/industries

23 MEMBERS OF KBI (1) RESEARCH AND DEVELOPMENT CENTERS Universities (Public - Private) Universitas Diponegoro Universitas Indonesia Universitas Soedirman Universitas Brawijaya Universitas Udayana Inst Teknologi Indonesia Univ Muhamadiyah Malang Universitas Lampung Universitas Surabaya Universitas Negeri Malang

24 MEMBERS OF KBI (2) RESEARCH AND DEVELOPMENT CENTER ON BIOTECHNOLOGY Mininistry of Research and Technology Center for the assessment biotech (BPPT) Center for the assessment and application bioindustry technology (BPPT) Starch Technology Center (BPPT) LIPI Research Center for Biotechnology Research Center for Chemistry Department of Agriculture Research Center of Agriculture & Genetics Resources Research Center for Horticuluture Biotech Research Unit for Crops Estate

25 MEMBERS OF KBI (3) INSTITUTIONS FROM PRIVATE SECTORS/ INDUSTRIES PT. ESA MEDIKA MANDIRI PT SENTRA BIOSAINS DINAMIKA PT MONAGRO KIMIA PT FAJAR MAS MURNI PT EAST WEST SEED INDONESIA HOSPITALS : Rajawali Hospital Tegalrejo Hospital

26 ROLE OF INDONESIA BIOTECHNOLOGY CONSORTIUM GOVERNMENT: POLICY IN BIOTECHNOLOGY SECTOR MEMBERS: SHARING INFORMATION AND RESOURCES JOINT ACTIVITIES INDONESIA BIOTECHNOLOGY CONFERENCE

27 KBI involves in preparing a concept of Strategic Plan of the Development of Biotechnology in Indonesia (SPDBI), from This effort was under the coordination of the Ministry of Research and Technology Strategic Plan of the Development of Biotechnology in Indonesia

28 Medicine and human health; Agriculture, food production, and fisheries; Industries, environment protection and remediation Biotechnology applications in three main fields have been elaborated in SPDBI:

29 Genetics disorders, Infectious diseases, Degenerative and malignancy diseases Biotechnology Research Priorities in the field Medicine and human health

30 Isolation and identification of abiotic stress resistance gene(s) markers Field tests for efficacy and food safety, Development of diagnostic kit for marine pollutant and pathogens Biotechnology Research Priorities in the field Agriculture, and marine

31 Development of recombinant vaccine production Development of novel antibiotics from local microbes Environment protection and bioremediation Biotechnology Research Priorities in the field of industries, environments protection and remediation

32 Infrastructure development, Regulatory/cultural environment, Policy development, Human resource development, Finance and resource mobilization The critical success factors for the development of biotechnology:

33 Socio-cultural and esthetical Religious and ethical norm

34 MOLECULAR BIOTECHNOLOGY IN INDONESIA

35 Biotechnology application in food production in Indonesia Tissue culture Marker aided selection Transgenesis Genomics – functional genomics –

36 Tissue culture Plant tissue culture and micropropagation techniques are well established in several laboratories Commercial production : banana, oil palm, orchid, teak and fast growing trees

37 Transgenic Indonesian aromatic rice resistant to yellow stem borer insect – approved for limited field trial – LIPI (Indonesian Institute of Sciences) λHindIII cry1Ab transgenicNon transgenic

38 Other transgenic plants develop in Indonesia i.e.:

39 Applications Functional genomics proteomicsProteome Protein level Protein interactions Structure/function DNA Microarray transcriptomicsTranscriptome Global gene regulation Differential gene expression Data mining Functional analysis of unknown ORFs Metabolome Kinetic parameter Modeling metabolic pwMetabolome Functional Genomics Genome sequence sequence Bioinformatics Statistics Linking database Pattern recognition Whole cell simulations

40

41

42

43

44

45

46 Recommendations 1. Considering the limited financial and human resources Indonesia, therefore, focus of the focus of all Biotechnology field must be taken 2. The Government must STIMULATE INNOVATION by giving TAX INCENTIVES to industries doing R&D 3. Efforts must be made to Facilitate Government- University-Industry cooperation 4. Applied Research in Universities and Government institutions should be done in close cooperation with industries 5. BINASIA should become the communication hub for International Cooperation and Technology Transfer

47 Recommendations (cont. ……………..) 6. In order to understand better on BINASIA, IBC –particularly IBC members institutions- are encouraged to open the website and to fill their specific activities accordingly. 7. IBC periodical meeting should cover report on the progress of IBC member institutions to engage with the respective institution(s) from other BINASIA member countries.

48


Download ppt "OVERVIEW BIOTECHNOLOGY IN INDONESIA T.Basuki, L.B.S. Kardono & M. Hanafi Research Center for Chemistry Indonesian Institute of Sciences (LIPI)"

Similar presentations


Ads by Google